Cocrystal Pharma (COCP) Operating Income (2010 - 2026)
Cocrystal Pharma (COCP) posted Operating Income of -$2.4 million for Q1 2026, up 5.04% sequentially from -$2.5 million in Q4 2025, and down 0.64% YoY from -$2.4 million in Q1 2025.
Cocrystal Pharma (COCP) Operating Income (2010 - 2026) Analysis & Trends
Cocrystal Pharma has reported Operating Income for 16 years, with the latest figure at -$2.4 million in Q1 2026.
- Quarterly Operating Income fell 0.64% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.0 million (up 43.75% YoY) and the FY2025 annual result came in at -$9.0 million, up 49.55% from the prior year.
- Operating Income grew to -$2.4 million in Q1 2026 per COCP's latest filing, from -$2.5 million in the prior quarter.
- Over five years, Operating Income peaked at -$2.1 million in Q3 2025 and troughed at -$24.4 million in Q2 2022.
- A 5-year average of -$5.1 million and a median of -$4.3 million in 2023 frame the typical range for Operating Income.
- The sharpest annual moves came in 2022 and 2023: Operating Income tumbled 538.14% in 2022, then soared 82.24% in 2023.
- Over 5 years, Operating Income stood at -$4.5 million in 2022, then decreased by 3.64% to -$4.7 million in 2023, then surged by 30.78% to -$3.2 million in 2024, then grew by 23.19% to -$2.5 million in 2025, then gained by 5.04% to -$2.4 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$2.4 million, -$2.5 million, and -$2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | Cocrystal Pharma | 15.65 Mn | 13.33 Mn | - | -3.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.18 Mn |
| Mar 31, 2026 | -2.36 Mn |
| Dec 31, 2025 | -2.48 Mn |
| Sep 30, 2025 | -2.09 Mn |
| Jun 30, 2025 | -2.11 Mn |
| Mar 31, 2025 | -2.34 Mn |
| Dec 31, 2024 | -3.23 Mn |
| Sep 30, 2024 | -5.04 Mn |
| Jun 30, 2024 | -5.45 Mn |
| Mar 31, 2024 | -4.16 Mn |
| Dec 31, 2023 | -4.67 Mn |
| Sep 30, 2023 | -4.44 Mn |
| Jun 30, 2023 | -4.34 Mn |
| Mar 31, 2023 | -5.11 Mn |
| Dec 31, 2022 | -4.50 Mn |
| Sep 30, 2022 | -5.69 Mn |
| Jun 30, 2022 | -24.43 Mn |
| Mar 31, 2022 | -4.21 Mn |
| Dec 31, 2021 | -3.70 Mn |
| Sep 30, 2021 | -3.95 Mn |